Ameliorative effect of Luffa acutangula Roxb. on doxorubicin induced cardiac and nephrotoxicity in mice

Indian Journal of Experimental Biology

Volumn 51, Issue 2, 2013, Pages 149-156

  Jadhav, Vishal B ^a   Thakare, Vishnu N ^b   Suralkar, Anupama A ^a   Naik, Suresh R ^b  

^a DR D Y PATIL INSTITUTE OF PHARMACEUTICAL SCIENCES AND RESEARCH   (India)

^b Sinhgad Technical Education Society   (India)

Author keywords

Antioxidants; Biomarkers; Cardioprotective; Doxorubicin; Luffa acutangula; Nephroprotective activity

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; DOXORUBICIN; PLANT EXTRACT;

ANIMAL; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CHEMISTRY; DRUG EFFECT; FEMALE; HEART MUSCLE; KIDNEY; KIDNEY DISEASE; LUFFA; MALE; METABOLISM; MOUSE; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHYTOTHERAPY; STAINING; TOXICITY TESTING;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DOXORUBICIN; FEMALE; KIDNEY; KIDNEY DISEASES; LUFFA; MALE; MICE; MYOCARDIUM; PHYTOTHERAPY; PLANT EXTRACTS; STAINING AND LABELING; TOXICITY TESTS, ACUTE;

EID: 84873888981     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Blum R H & Carter S K, Adriamycin: a new anticancer drug with significant clinical activity, Ann Int Med, 80 (1974) 249
2. Casazza A M, Preclinical selection of new anthracyclines, Cancer Treatment Report, 70 (1986) 439
3. Chabner B A, Antineoplastic agents. in Goodman and Gilman's The pharmacological basis of therapeutics, (McGraw-Hill Co Press, New York) 2001 389
4. Lenaz L & Page J, Cardiotoxicity of Adriamycin and related anthracyclines, Cancer Treat Rev, 3 (1976) 111
5. Gorgan M, Effect of vitamin E on Adriamycin induced nephrotoxicity at the ultrstructural level in Guinea pigs, Nephron, 82 (1999) 155
6. Zon S, Doxorubicin induced persistent oxidative stress to cardiac myocytes, Toxicol Lett, 121 (2000) 151
7. Bier C C & Jaenke R S, Function of myocardial mitochondria in the Adriamycin induced cardiomyopathy of rabbits, J National Cancer Inst, 57 (1976) 1091
8. Myers C E, McGuire W & Young R, Adriamycin: The role of lipid peroxidation in cardiac toxicity and tumor response, Science, 197 (1977) 165
9. Bristow M R, Sageman W S, Scott R H, Billingham M E, Bowden R E, Kernoff R S, Snidow G H & Daniels J R, Acute and chronic vascular effects of doxorubicin in dog, J Cardiovascular Pharmacol, 2 (1980) 487
10. Geetha A & Devi C S, Effect of Doxorubicin on heart mitochondrial enzymes in rats: A protective role for alphatocopherol, Indian J Exp Biol, 30 (1992) 615
11. Ilskowic N & Singal P K, Lipid lowering: An important factor in preventing Adriamycin induced heart failure, Am J Pathol, 150 (1997) 727
12. Daoud S S, Cell membrane as targets for anticancer drug action, Anticancer Drugs, 3 (1992) 443
13. Saad S Y, Najja T A & Al-Rikabi A C, The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats, Pharmacol Res, 43 (2001) 211
14. Fadillioglu E, Oztas E & Erdogan H, Protective effect of caffeic acid phenethylesteron doxorubicin induced cardiotoxicity in rats, J Appl Toxicol, 24 (2004) 47
15. Legha S S, Wang Y M, Mackay B, Ewer M, Hortobagyi G N & Benjamin R S, Clinical and pharmacological investigation of the effects of alpha-tocopherol on Adriamycin cardiotoxicity, Ann NY Acad Sci, 393(1982) 411
16. Vaclavikova R, Kondrová E, Ehrlichová M, Boumendjel A, Kovář J, Stopka P, Souček P & Gut I, The effect of flavonoids derivatives on doxorubicin transport and metabolism, Bioorg Med Chem, 16 (2008) 2034
17. Naik S R, Thakare V N & Patil S R, Protective effect of curcumin on experimentally induced inflammation, hepatotoxicity and cardiotoxicity in rats: Evidence of its antioxidant property, Exp Toxicol Pathol, 63 (2011) 419
18. Ng TB, Proteins with abortifacient, ribosome inactivating, immunomodulatory, antitumour and anti-AIDS activities from Cucurbitaceae plants. General Pharmacology: The Vascular system 23 (1992) 575
19. Misar A V, Upadhye A S & Mujumdar A M, CNS depressant activity of Luffa acutangula Var. amara C. B. Clarke fruits in mice, Indian J Pharm Sci, 66 (2004) 463
20. Prabhakar K, & Jebanesan A, Larvicidal efficacy of some Cucurbitaceous plant leaf extracts against Culex quinquefasciatus (Say), Bio Res Technol, 95 (2004) 113
21. Ansari N M, Houlihan L, Hussain B & Pieroni A, Antioxidant activity of five vegetables traditionally consumed by South-Asian Migrants in Bradford, Phytother Res, 19 (2005) 907
22. Jadhav V B, Thakare V N, Suralkar A A, Deshpande AD & Naik SR, Hepatoprotective activity of Luffa acutangula against CCl4 and rifampicin induced liver toxicity in rats: A biochemical and histopathological evaluation, Indian J Exp Biol 48 (2010) 822
23. Chaudhari G, Chemical constituents of Luffa amara Roxb.: part I- Isolation of a crystalline bitter from the seeds, J Sci Indust Res, 10B (1951) 26
24. Schilling E E & Heiser C B, Flavonoids and the systematics of Luffa, Biochem Syst Ecol, 9 (1981) 263
25. Nagao T, Tanaka R & Okabe H, Studies on the constituents of Luffa acutangula Roxb. II. Structure of acutosides H-I, oleanolic acid saponins isolated form the seeds, Chem Pharm Bull, 39 (1991) 889
26. Nagao T, Tanaka R & Okabe H, Studies on the constituents of Luffa acutangula Roxb. I. Structure of acutosides A-G, oleanane type triterpene saponins isolated from the herb, Chem Pharm Bull, 39 (1991a) 599
27. Nadkarni K M, Luffa acutangula Var. amara C. B. Clarke, Indian materia medica, (Popular Prakashan, Mumbai) 2000 751
28. Wang H & Ng T B, Luffangulin, a novel ribosome inactivating peptide from ridge gourd (Luffa acutangula) seeds, Life Sci, 70 (2002) 899
29. Hou X Chen M, Chen L, Edward J M, Xie J & Huang M, X-ray sequence and crystal structure of luffaculin I, a novel ribosome type I ribosome-inactivating protein, BMC Structural Biol, 7 (2007) 29
30. Kandlakunta B, Rajendran A, & Thingnganing L, Carotene content of some common (cereals, pulses, vegetables, spices and condiments) and unconventional sources of plant origin, Food Chem, 106 (2008) 85
31. Organization of economic and corporation development. Guidelines for testing of chemicals-acute oral toxicity up and down procedure, (2006), 425
32. Reitman S & Frankel S, In vitro determination of transaminase activity in serum, Am J Clin Pathol, 28 (1957).
33. Amdor E, Dorfman R & Wacker W E, Determination of lactate dehydrogenase, Clin Chem, 9 (1963) 391
34. Rosalki S B, An improved procedure for serum creatine phosphokinase determination, J Lab Clin Med, 69 (1967) 696
35. Ohkawa H & Nobuko K, Assay of lipid peroxide in animal tissue by thiobarbituric acid reaction, Anal Biochem, 95 (1979) 351
36. Ellman G L, Tissue sulfhydryl group, Arch Biochem Biophysics, 82 (1999) 70
37. Clairborne A, Catalase activity; in CRS handbook of methods in oxygen radical research edited by RA Greenwald (CRS Press, Boca Raton) 1991, 283
38. Zigman S & Sun M, An improved spectrophotometric assay for superoxide dismutase based on epinephrine auto oxidation, Anal Biochem, 90 (1978) 81
39. Fadillioglu E, Erdogan H, Sogut S & Kuku I, Protective effect of erdosteine against doxorubicin induced cardiomyopathy in rats, J Appl Toxicol 23 (2003) 71
40. Yagmurca M & Erdogan H, Caffeic acid phenethyl ester as a protective against doxorubicin nephrotoxicity in rats, Clinica Chimica Acta, 348 (2004) 27
41. Bachur N, Gordon S, Gee M & Kon H, NADPHcytochrome P450 reductase activation of quinine anticancer agents to free radicals, Proc Natl Acad Sci, 76 (1979) 954
42. Lee V, Randhawa, A K & Singal P K, Adriamycin induced myocardial dysfunction in vitro is mediated by free radicals, Am J Physiol, 261(1991) H989
43. Karaman A, Binici DN, Kabalar ME, Dursun H & Kurt A, Protective effects of leflunomide against ischemia reperfusion injury of the rats liver, Ped Sur Int, 22 (2006) 428
44. Shah S, Role of reactive oxygen metabolites in experimental glomerular disease, Kidney Int, 35(1989) 1093
45. Deman A, Ceyssens B, Pauwels M, Zhang J G, Van den Houte K, Verbeelen D & Vanden Branden C, Altered antioxidant defense in a mouse adriamycin model of glomerulosclerosis, Nephrol Dial Transplant, 16 (2001)147
46. Dolphin D, Poulson R & Avramovic O, Glutathione: Chemical, biochemical and medical aspects (J. Wiley and Sons). 1989
47. Thomas C E & Aust S D, Release of iron from ferritin by cardiotoxic anthracycline antibiotics, Arc Biochem Biophysics, 248 (1986) 684
48. Cini N G, Neri B, Bandinelli M, Del-Tacca M, Danesi R & Ricardi R, Anthracycline cardiotoxicity: in vivo and in vitro effects on biochemical parameters and heart ultrastructure of the rat, Oncol, 48 (1991) 327
49. Hershko C, Link G, Tzahor M & Pinson A, The role of iron and iron chelators in anthracycline cardiotoxicity, Leukemia and Lymphoma, 11 (199) 207
50. Yin X, Wu H, Chen Y & Kang Y J, Induction of antioxidants by adriamycin in mouse heart, Biochem Pharmacol, 56 (1998) 87
51. Meister A, New aspects of glutathione biochemistry and transport selective alterations of glutathione metabolism, Nutri Rev, 42 (1984) 397
52. Morimoto T, Sunagawa Y, Kawamura T, Takaya T, Wada H & Nagasawa A, The dietary compound curcumin inhibit p300 histone acetyltransferase activity and prevents heart failure in rats, J Clin Invest, 118 (2008) 868
53. Lil J L, Startman E W & Lardy H A, Antioxidant enzyme systems in rat liver and skeletal muscle, Arch Biochem Biophysics, 263 (1988) 150
54. Stallings W, The Three-dimensional structure of iron superoxide dismutase: Kinetics and structural comparisons with Cu/Zn and Mn dismutases, in Oxygen radicals in chemistry and biology. (Walter de Gruyter & Co, Berlin) 1984
55. Zamocky M & Koler F, Understanding the structure and functions of catalases: Clues from molecular evolution and in vitro mutagenesis, Prog Biophysics Mol Biol, 72 (1999) 9
56. Deisseroth A & Dounce A L, Catalase: physical and chemical properties, Mechanism of catalysis, and Physiological role, Physiol Rev, 50 (1970) 319
57. Beyer W, Superoxide dismutases, Prog Nucleic Acid Res Mol Biol, 40 (1991) 221
58. Naik S R & Panda V S, Antioxidant and hepatoprotective effects of Ginkgo biloba Phytosomes in carbon tetrachlorideinduced liver injury in rodents, Liver Int, 27 (2007) 393
59. Panda V S & Naik SR, Cardioprotective acitivity of Ginkgo biloba Phytosomes in isoproterenol induced myorcardial necrosisi in rats: A biochemical and histoarchitectural evaluation, Exp Toxicol Pathol, 60 (2008) 397.